Black Friday saleUp to 70% OFF
555

WAVERLEY PHARMA INC.

No trades
See on Supercharts
Overview
Financials News Discussions Seasonals

5GZ chart


Full chart

Key stats


Market capitalization
‪735.85 K‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0285 EUR
Net income (FY)
‪−1.52 M‬ EUR
Revenue (FY)
‪281.70 K‬ EUR
Shares float
‪13.55 M‬
Beta (1Y)
−0.83

About WAVERLEY PHARMA INC


Sector
Health Technology
CEO
Larry Thiessen
Headquarters
Winnipeg
Website
waverleypharma.com
Founded
2014
FIGI
BBG00X9DLZ62
Waverley Pharma, Inc. is a pharmaceutical company, which engages in the commercialization and development of oncology drugs. Its products include Pemetrexed, WAV-102, and PARP-1 Inhibitors. The company was founded in 2014 and is headquartered in Winnipeg, Canada.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

5GZ news



Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange WAVERLEY PHARMA INC. stocks are traded under the ticker 5GZ.
5GZ reached its all-time high on Feb 16, 2021 with the price of 0.1530 EUR, and its all-time low was 0.0065 EUR and was reached on Feb 2, 2024. View more price dynamics on 5GZ chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track WAVERLEY PHARMA INC. financials in yearly and quarterly reports right on TradingView.
5GZ net income for the last quarter is ‪−235.24 K‬ EUR, while the quarter before that showed ‪−180.70 K‬ EUR of net income which accounts for −30.18% change. Track more WAVERLEY PHARMA INC. financial stats to get the full picture.
No, 5GZ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. WAVERLEY PHARMA INC. EBITDA is ‪−732.78 K‬ EUR, and current EBITDA margin is −214.10%. See more stats in WAVERLEY PHARMA INC. financial statements.
Like other stocks, 5GZ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade WAVERLEY PHARMA INC. stock right from TradingView charts — choose your broker and connect to your account.